CASTLE BIOSCIENCES, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
CASTLE BIOSCIENCES, INC. (CSTL) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $11.59 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Shareholders' Equity › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-07-30
- CASTLE BIOSCIENCES, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $11.59M, a 3.40% increase year-over-year.
- CASTLE BIOSCIENCES, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $9.78M, a 12.55% decline year-over-year.
- CASTLE BIOSCIENCES, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $12.10M, a 7.12% decline year-over-year.
- CASTLE BIOSCIENCES, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $11.21M, a 14.96% decline year-over-year.
- CASTLE BIOSCIENCES, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $45.89M, a 8.80% decline from fiscal 2024.
- CASTLE BIOSCIENCES, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $50.32M, a 1.76% decline from fiscal 2023.
- CASTLE BIOSCIENCES, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $51.22M.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $11.59M 10-Q · filed 2026-07-30 | $21.36M derived: sum of 2 quarters · filed 2026-07-30 | ||
| 2026-03-31 | $9.78M 10-Q · filed 2026-07-30 | |||
| 2025-12-31 | $45.89M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $12.10M 10-Q · filed 2025-11-03 | $23.31M derived: sum of 2 quarters · filed 2026-07-30 | $34.49M derived: sum of 3 quarters · filed 2026-07-30 | |
| 2025-06-30 | $11.21M 10-Q · filed 2026-07-30 | $22.39M derived: sum of 2 quarters · filed 2026-07-30 | ||
| 2025-03-31 | $11.18M 10-Q · filed 2026-07-30 | |||
| 2024-12-31 | $50.32M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $13.03M 10-Q · filed 2025-11-03 | $26.21M derived: sum of 2 quarters · filed 2025-11-03 | $38.88M derived: sum of 3 quarters · filed 2025-11-03 | |
| 2024-06-30 | $13.18M 10-Q · filed 2025-11-03 | $25.85M derived: sum of 2 quarters · filed 2025-11-03 | ||
| 2024-03-31 | $12.68M 10-Q · filed 2025-11-03 | |||
| 2023-12-31 | $51.22M 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |